Hepatitis C—Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up
Open Access
- 7 July 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4801
Abstract
Hepatitis C virus (HCV) infection is a major public health concern, with more than 58 million people chronically infected worldwide. The management of HCV, once the domain of specialists only, has been revolutionized by the advent of direct-acting antiviral therapies. To reduce the burden of HCV in the United States (US), emphasis is now being placed on the involvement of primary care physicians in the management of HCV patients. Inclusion of more primary care providers in the HCV diagnosis and treatment initiatives can assist in achieving the goal of HCV elimination, especially in the medically underserved areas. To actively engage in the management of HCV, primary care providers must understand its epidemiology, risk factors, natural history, current treatment regimen, and potential complications. This manuscript reviews these key areas, along with presenting the cost-effectiveness of treatment and evidence-based guidelines for follow-up care in adults with chronic HCV infection who have undergone HCV treatment. Equipped with this foundational knowledge about HCV management, primary care physicians can play a vital role in eliminating HCV.Keywords
This publication has 86 references indexed in Scilit:
- County‐Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005‐2017Hepatology, 2021
- Screening for Hepatitis C Virus Infection in Adolescents and AdultsJAMA, 2020
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus InfectionHepatology, 2020
- Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016JAMA Network Open, 2018
- Cost‐effectiveness of hepatitis C treatment for patients in early stages of liver diseaseHepatology, 2015
- Chronic hepatitis C virus (HCV) disease burden and cost in the United StatesHepatology, 2012
- Prognostic Value of Ishak Fibrosis Stage: Findings From the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis TrialHepatology, 2010
- Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infectionHepatology, 2008
- Reconsidering Medication Appropriateness for Patients Late in LifeArchives of internal medicine (1960), 2006
- Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant womenHepatology, 2000